Details of the Drug

General Information of Drug (ID: DMMRSK1)

• Drug Name: AE-37
• Synonyms: Breast cancer vaccine, Antigen Express; AE-37, Antigen Express; HER-2/neu vaccine, Antigen Express; HER-2/neu vaccine (breast cancer/prostate cancer), Antigen Express; Ii-key/HER-2/neu (776-790)

Indication

Disease Entry	ICD 11	Status	REF
Breast cancer	2C60-2C65	Phase 2	[1]
Prostate cancer	2C82.0	Phase 1	[2]

• Drug Type: Small molecular drug
• Chemical Identifiers:
  Formula: C19H23NO
  Canonical SMILES: CN(C)CC1CCOC1(C2=CC=CC=C2)C3=CC=CC=C3
  InChI: InChI=1S/C19H23NO/c1-20(2)15-18-13-14-21-19(18,16-9-5-3-6-10-16)17-11-7-4-8-12-17/h3-12,18H,13-15H2,1-2H3
  InChIKey: BOTHKNZTGGXFEQ-UHFFFAOYSA-N
• Cross-matching ID:
  PubChem CID: 9882189
  ChEBI ID: CHEMBL4297224
  CAS Number: 195615-83-9
  UNII: 9T210MMZ3F
  DrugBank ID: DB05592
  TTD ID: D0G3BN
• Drug-Molecule Activity Atlas (DMA)NEW: Click to Jump to the Detailed DMA Information of This Drug
• Drug ADMET Endpoint Profile (DAE)NEW: Click to Jump to the Detailed DAE Information of This Drug
• Repurposed Drugs (RPD): Click to Jump to the Detailed RPD Information of This Drug

References

• [1] ClinicalTrials.gov (NCT00524277) Vaccine Therapy in Treating Patients With Breast Cancer. U.S. National Institutes of Health.
• [2] Clinical pipeline report, company report or official report of the Pharmaceutical Research and Manufacturers of America (PhRMA)